Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

PreVent-ACaLL Short-term combined acalabrutinib and venetoclax treatment of newly diagnosed patients with CLL at high risk of infection and/or early treatment, who do not fulfil IWCLL treatment criteria for treatment. A randomized study with extensive immune phenotyping

Caspar Da Cunha-Bang, MD PhD, Rudy Agius, Arnon P. Kater, Mark-David Levin, MD PhD, Anders Österborg, MD PhD, Mattias Mattsson, MD, Carsten Utoft Niemann, MD PhD

Blood (2019) 134 (Supplement_1): 4304.

https://doi.org/10.1182/blood-2019-121907

Published: 2019

Journal Articles

Rivaroxaban Reduces the Levels of Extracellular Vesicles in Patients with Venous Thromboembolism and Non-Valvular Atrial Fibrillation

Sarah Kelliher, MBBS, Luisa Weiss, MSc, Paulina Szklanna, PhD, Karl Egan, PhD, Tadhg Prendiville, MB BCh BAO, Eric Moran, MB BCh BAO, Georgi Petrov, MB BCh BAO, Alfonso Blanco, PhD, Aine Lennon, MSc, Sean Murphy, MD, John Keaney, MD, Fionnuala Ni Ainle, PhD, Patricia Maguire, PhD

Blood (2019) 134 (Supplement_1): 2437.

https://doi.org/10.1182/blood-2019-126166

Published: 2019

Journal Articles

Pharmacokinetics of Ticagrelor in Infants and Toddlers Aged <24 Months with Sickle Cell Disease

Baba PD Inusa, MD, Adlette Inati, MD, Philip Maes, MD, Jessie Githanga, MBChB, MMed, Miguel R. Abboud, MD, Maurizio Miano, Elena Cela, Videlis Nduba, Mohammad Niazi, Magnus Åstrand, Kevin Persson, Anders Rikard Berggren, MD PhD, Glenn Carlson, MD

Blood (2019) 134 (Supplement_1): 1005.

https://doi.org/10.1182/blood-2019-129855

Published: 2019

Journal Articles

Ticagrelor Modulates Proliferation in Multiple Myeloma Via P1 and P2 Receptor-Mediated Mechanisms

Elan Meltzer, Aranzazu Mediero, Carl Whatling, Jeffrey S Berger, MD, Bruce Cronstein

Blood (2016) 128 (22): 5694.

https://doi.org/10.1182/blood.V128.22.5694.5694

Published: 2016

Journal Articles

Platelets and the Tumor Cell Microenvironment

Tatiana V. Byzova, PhD, Bethany A. Kerr, PhD, Weiyi Feng, MD, Patrick McCabe, PhD

Blood (2013) 122 (21): SCI-32.

https://doi.org/10.1182/blood.V122.21.SCI-32.SCI-32

Published: 2013

Journal Articles

Miniaturized T2MR Magnetic Resonance System for Analysis of Hemostasis and Detection of Impaired and Prothrombotic Blood Disorders

Douglas B. Cines, MD, Tatiana Lebedeva, M.D. Ph.D., M. Anna Kowalska, PhD, Mortimer Poncz, MD, Lubica Rauova, MD, PhD, Adam Cuker, MD, MS, John W. Weisel, Ph.D., Walter Massefski, Ph.D., Vyacheslav Papkov, M.S., Edward C. Thayer, Ph.D., Thomas J. Lowery, Ph.D.

Blood (2012) 120 (21): 1118.

https://doi.org/10.1182/blood.V120.21.1118.1118

Published: 2012

Journal Articles

Antibodies causing thrombocytopenia in patients treated with RGD-mimetic platelet inhibitors recognize ligand-specific conformers of α IIb /β 3 integrin

Daniel W. Bougie, Mark Rasmussen, Jieqing Zhu, Richard H. Aster

Blood (2012) 119 (26): 6317–6325.

https://doi.org/10.1182/blood-2012-01-406322

Published: 2012

Includes: Supplemental data

Journal Articles

Anti-Coagulation Agents Provide a Mechanism to Inhibit Tumor Cells From Hijacking the Angiogenic Potential of Platelets

Elisabeth M. Battinelli, MD, PhD, Beth Markens, Joseph E. Italiano, Jr., PhD

Blood (2011) 118 (21): 1149.

https://doi.org/10.1182/blood.V118.21.1149.1149

Published: 2011

Journal Articles

Identification of a Novel Par1 inhibitor Using a Chemical Genetic Screen

Robert Flaumenhaft, Lynn VerPlank, James R. Dilks, Daniel A. Smith, Price Blair, Albert T. Mairuhu, Joseph Negri, Chris Dockendorff, Lawrence McPherson, Michelle Palmer, Stuart L. Scheiber

Blood (2010) 116 (21): 2018.

https://doi.org/10.1182/blood.V116.21.2018.2018

Published: 2010

Journal Articles

STAT3 Regulates Collagen-Induced Platelet Aggregation Independent of Its Transcription Factor Activity

Zhou Zhou, MD, PhD, Francisca C. Gushiken, MD, Angela Bergeron, Vinod K. Vijayan, PhD, Rolando Rumbaut, MD, Jose A. Lopez, MD, Jing-fei Dong, MD, PhD

Blood (2010) 116 (21): 157.

https://doi.org/10.1182/blood.V116.21.157.157

Published: 2010

Journal Articles

Antibodies Causing Thrombocytopenia in Patients Given RGD-Mimetic Platelet Inhibitors Recognize Drug-Induced (and drug-specific) Conformational Epitopes Adjacent to the RGD Recognition Site of Gpiib/Iiia.

Daniel W. Bougie, PhD, Mark Rasmussen, Jessica Ruben, Richard H. Aster, MD

Blood (2009) 114 (22): 889.

https://doi.org/10.1182/blood.V114.22.889.889

Published: 2009

Journal Articles

A Chemical Genetic Analysis of Platelet Activation.

Robert Flaumenhaft, Lynn VerPlank, James R. Dilks, Price S. Blair, Albert Mairuhu, Joseph Negri, Jason Burbank, Gil Walzer, Tyler Aldredge, Chris Dockendorff, Robert Gould, Lawrence MacPherson, Michelle Palmer

Blood (2009) 114 (22): 4009.

https://doi.org/10.1182/blood.V114.22.4009.4009

Published: 2009

Journal Articles

Drug Inhibition of GPIb.

Hans Deckmyn, PhD, Simon F. De Meyer, PhD, Karen Vanhoorelbeke, PhD

Blood (2009) 114 (22): SCI-38.

https://doi.org/10.1182/blood.V114.22.SCI-38.SCI-38

Published: 2009

Journal Articles

Double jeopardy

Richard H. Aster

Blood (2009) 114 (6): 1135–1136.

https://doi.org/10.1182/blood-2009-06-223503

Published: 2009

Journal Articles

Induction of Insulin Resistance by Adipokines in Human Megakaryocytes

Anja J Gerrits, Eelo Gitz, Arnold C Koekman, Frank L Visseren, MD, PhD, Jan-Willem Akkerman, PhD

Blood (2008) 112 (11): 5390.

https://doi.org/10.1182/blood.V112.11.5390.5390

Published: 2008

Journal Articles

The Contact Activation Coagulation Pathway Is Involved in (Recurrent) Coronary Disease.

Arne W.J.H. Dielis, MD, Jose W.P. Govers-Riemslag, PhD, Mark Winkens, MD, Patricia Wijers-Holys, BSc, Karly Hamulyak, MD PhD, Henri M.H. Spronk, PhD, Johannes Waltenberger, MD PhD, Hugo ten Cate, MD PhD

Blood (2007) 110 (11): 129.

https://doi.org/10.1182/blood.V110.11.129.129

Published: 2007

Journal Articles

RGD-Substituted High Molecular Weight Hyper-Branched Polyglycerols (HPG) Are Effective Platelet Inhibitors.

Jerry G. Zhang, BSc, Oren Krajden, B.Sc., Rajesh K. Kainthan, Ph.D., Jayachandran N. Kizhakkedathu, Ph.D., Maria I.C. Gyongyossy-Issa, Ph.D

Blood (2007) 110 (11): 925.

https://doi.org/10.1182/blood.V110.11.925.925

Published: 2007

Journal Articles

Characterizing Factor VIII Inhibitor Resistance of Platelet-Delivered Factor VIII in the Treatment of Hemophilia A.

Jamie E. Gewirtz, BA, Lubica Rauova, Ph.D., Mortimer Poncz, M.D.

Blood (2007) 110 (11): 781.

https://doi.org/10.1182/blood.V110.11.781.781

Published: 2007

Journal Articles

Monitoring of Clopidogrel Using Multiple Electrode Aggregometry.

Andreas Calatzis, MD, Franz Theisen, MD, Armin J. Reininger, MD, Michael Spannagl, MD

Blood (2006) 108 (11): 883.

https://doi.org/10.1182/blood.V108.11.883.883

Published: 2006

Journal Articles

Recombinant Human FVIIa Reduces Heparin and Low Molecular Weight Heparin (LMWH)-Induced Bleeding in Rats.

Brian Lauritzen, Mikael Tranholm, Peter B. Johansen, Mirella Ezban

Blood (2005) 106 (11): 2149.

https://doi.org/10.1182/blood.V106.11.2149.2149

Published: 2005

NARROW

PreVent-ACaLL Short-term combined acalabrutinib and venetoclax treatment of newly diagnosed patients with CLL at high risk of infection and/or early treatment, who do not fulfil IWCLL treatment criteria for treatment. A randomized study with extensive immune phenotyping

Rivaroxaban Reduces the Levels of Extracellular Vesicles in Patients with Venous Thromboembolism and Non-Valvular Atrial Fibrillation

Pharmacokinetics of Ticagrelor in Infants and Toddlers Aged <24 Months with Sickle Cell Disease

Ticagrelor Modulates Proliferation in Multiple Myeloma Via P1 and P2 Receptor-Mediated Mechanisms

Platelets and the Tumor Cell Microenvironment

Miniaturized T2MR Magnetic Resonance System for Analysis of Hemostasis and Detection of Impaired and Prothrombotic Blood Disorders

Antibodies causing thrombocytopenia in patients treated with RGD-mimetic platelet inhibitors recognize ligand-specific conformers of α IIb /β 3 integrin

Anti-Coagulation Agents Provide a Mechanism to Inhibit Tumor Cells From Hijacking the Angiogenic Potential of Platelets

Identification of a Novel Par1 inhibitor Using a Chemical Genetic Screen

STAT3 Regulates Collagen-Induced Platelet Aggregation Independent of Its Transcription Factor Activity

Antibodies Causing Thrombocytopenia in Patients Given RGD-Mimetic Platelet Inhibitors Recognize Drug-Induced (and drug-specific) Conformational Epitopes Adjacent to the RGD Recognition Site of Gpiib/Iiia.

A Chemical Genetic Analysis of Platelet Activation.

Drug Inhibition of GPIb.

Double jeopardy

Induction of Insulin Resistance by Adipokines in Human Megakaryocytes

The Contact Activation Coagulation Pathway Is Involved in (Recurrent) Coronary Disease.

RGD-Substituted High Molecular Weight Hyper-Branched Polyglycerols (HPG) Are Effective Platelet Inhibitors.

Characterizing Factor VIII Inhibitor Resistance of Platelet-Delivered Factor VIII in the Treatment of Hemophilia A.

Monitoring of Clopidogrel Using Multiple Electrode Aggregometry.

Recombinant Human FVIIa Reduces Heparin and Low Molecular Weight Heparin (LMWH)-Induced Bleeding in Rats.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only